Summary
Different kidney diseases are often associated with high urinary excretion of N-acetyl-β-D-glucosaminidase (NAG), a lysosomal enzyme involved in the breakdown of glycoproteins, whose activity is also increased in diabetic patients with poor metabolic control or vascular complications. In order to evaluate the relationship between renal function and urinary NAG levels in diabetes mellitus, 30 type II diabetic patients without evidence of kidney disease and 18 control subjects were studied. In each subject 24-h urinary excretion rates of NAG (fluorimetric method), albumin and β2-microglobulin (radioimmunoassay), together with51Cr-EDTA clearance were performed. In diabetic patients urinary levels of NAG (356±25vs 162±9.2 nmol/h/mg creatinine, p<0.0001) and albumin (21±2.5vs 4.3±0.5 mg/24h, p<0.0001) were significantly higher than in the controls, while β2-microglobulin levels and51Cr-EDTA clearance did not differ in the two groups. Moreover in diabetic patients NAG and albumin levels were positively and significantly correlated (r=0.63, p<0.001). These results suggest that urinary NAG excretion rate may be altered early in diabetic patients with apparently normal renal function; its diagnostic value seems to be similar to that of the albumin excretion rate.
Similar content being viewed by others
References
Barratt M.: Proteinuria—Brit. med. J.287, 1489, 1983.
Bending J. J., Viberti G. C., Bilous R. W., Keen H. (Kroc Collaborative Study Group): Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria—Diabetes34 (Suppl. 3), 69, 1985.
Bomback F. M., Nakagawa S., Kumin S., Nitowsky H. M.: Altered lysosomal glycohydrolase activities in juvenile diabetes mellitus—Diabetes25, 420, 1976.
Chantler C., Garnett E. S., Parson V., Veal N.: Glomerular filtration rate measurement in man by the single injection method using51Cr-EDTA—Clin. Sci.37, 169, 1969.
Gibey R., Dupon J. L., Henry J. C.: Urinary N-acetyl-beta-glucosaminidase isoenzyme profiles: a tool for evaluating nephrotoxicity of amino-glycosides and cephalosporins—Clin. chim. Acta137, 1, 1984.
Goi G., Fabi A., Lorenzi R., Lombardo A., Tettamanti G., Burlina A. B., Pinelli L., Gaburro D.: Serum enzymes of lysosomal origin as indicators of the metabolic control in diabetes: comparison with glycated hemoglobin and albumin—Acta diabetol. lat.23, 117, 1986.
Hawthorne G. C., MacLellan J. R., Mythen M., Alberti K. G. M. M., Turner G. A.: Studies on glomerular basement membrane in experimental diabetes using lectin histochemistry in Wistar rats—Diabetologia29, 495, 1986.
Kohler E., Sheth K. J., Good T. A.: Urinary acid glycohydrolases as an index of kidney damage in juvenile diabetes mellitus—Acta diabetol. lat.16, 247, 1979.
Leaback D. H., Walker P. G.: Studies on glucosaminidase. The fluorimetric assay of N-acetyl-β-glucosaminidase —Biochem. J.78, 151, 1961.
Mogensen E.E.: Microalbuminuria in maturity onset, primarily type 2 (non-insulin-dependent) diabetes, predicts clinical proteinuria and early mortality—Diabetologia25, 181, 1983; Abstract #274.
Mogensen C. E.: Incipient and overt diabetic nephropathy, pathogenetic patterns and intervention studies. In:Sérrano-Ríos M., Lefèbvre P. S. (Eds): Diabetes 1985. Proc. 12th Congr. Int. Diabetes Fed., Madrid 1985. Excerpta Medica, Amsterdam, 1986; p. 691.
Paigen K., Peterson J.: Coordinacy of lysosomal enzyme excretion in human urine—J. clin. Invest.61, 751, 1978.
Parving H.-H., Oxenbøll B., Svendsen P. Aa., Christiansen J. S., Andersen A. R.: Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion—Acta endocrinol. (Kbh.)100, 550, 1982.
Perdichizzi G., Cucinotta D., Saitta A., Cavalieri A., Squadrito G.: Serum and urinary activities of beta-N-acetylglucosaminidase and beta-glucuronidase in diabetic patients—Acta diabetol. lat.20, 257, 1983.
Sheth J. K., Good T. A.: Urinary acidic hydrolases in renal diseases in children—Clin. Nephrol.10, 151, 1978.
Viberti G. C., Bilous R. W., MacKintosh D., Keen H.: Monitoring glomerular function in diabetic nephropathy: a prospective study—Amer. J. Med.74, 256, 1983.
Viberti G. C., Hill, R. D., Jarrett R. J., Argyropoulos A., Mahmud U., Keen H.: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus—Lanceti, 1430, 1982.
Viberti G. C., Keen H.: The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy—Diabetes33, 686, 1984.
Welwood J. M., Ellis, B. G., Prince R. G., Hammond K., Thompson A. E., Jones N. F.: Urinary N-acetyl-β-D-glucosaminidase activities in patients with renal disease—Brit. med. J.3, 408, 1975.
Williamson J. R., Kilo C.: Capillary basement membrane in diabetes—Diabetes32 (Suppl. 2), 96, 1983.
Wiseman M. J., Viberti G. C.: Genesis and evolution of proteinuria in diabetes mellitus—La Ricerca Clin. Lab.15, 9, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perdichizzi, G., Cucinotta, D., Fera, R. et al. Correlation between urinary activity of N-acetyl-β-d-glucosaminidase (NAG) and albumin excretion rate in type II (non-insulin-dependent) diabetic subjects. Acta diabet. lat 24, 149–155 (1987). https://doi.org/10.1007/BF02742853
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02742853